National
Cancer Institute Offers Funding for
Small Businesses more
|
|
|
Events Column |
|
|
|
Send your bioscience events to bkelly@curenet.org
and we will post them here.
|
|
|
|
|
CURE's
Annual Meeting and BioHaven Series
Showcase Connecticut Biopharma
From
the desk of Paul Pescatello, President and CEO of CURE
During the uncertain business climate of the past two years, Connecticut bioscience has provided a measure of stability to the local economy.
This important contribution was highlighted at CURE's Annual
Meeting. The stories in this issue of CURE News
underscore the vitality and significance of Connecticut
biopharma.
For
the full story |
|
Yale
Cell Biology Researcher Wins $1 Million Prize
James
Rothman, a Yale cell biologist, was among eight researchers named
Thursday as winners of this year’s $1 million Kavli
Prizes, which honor work in astrophysics, nanoscience, and
neuroscience. Rothman is one of three
recipients of the neuroscience prize for his work with cell
vesicles and the release of neurotransmitters, the chemical
messengers that send information between neurons.
For
the full story |
|
Healthcare
Reform Focus of CURE Annual Meeting
Uwe
Reinhardt Explains Legislation's Impact on Biopharma;
Awards Conferred on Pfizer, Jon Soderstrom, MannKind
Corporation and Boehringer Ingelheim
At
the CURE 2010 Annual Meeting, the CURE Award for Excellence
was presented to Pfizer for its investment in Alzheimer's
research. Jon Soderstrom of Yale OCR, MannKind, and
Boehringer Ingelheim also won awards.
Following the presentations, the audience heard from noted health care economist Professor Uwe Reinhardt of Yale and
Princeton.
For
the full story |
|
Ion
Torrent & 4 Biotechs Draw Venture Capital
Venture capital
investments in the Life Sciences area in the first quarter
of 2010 totaled $21.7 million, according to The
MoneyTree® Report, issued quarterly by PricewaterhouseCoopers
and the National Venture Capital Association, based on data
from Thomson Reuters.
For
the full story |
|
JS Genetics Presents
at CURE/Yale
BioHaven Series
The
company develops and markets sophisticated but
highly cost-effective DNA diagnostic tests for underserved medical conditions in newborns,
children, and adolescents. This focus grew out of the recognition that most
genetic tests require blood samples, have longer turn-around times, and are
expensive.
For
the full story |
|
Amarin Corporation
Focus of CURE/Yale BioHaven Presentation
Amarin Corporation is a
clinical-stage biopharmaceutical company focused on improving the treatment of
cardiovascular disease. The company is headquartered in
Dublin, Ireland, and has its research and development headquartered in Mystic,
CT.
For
the full story |
|
Jonathan Rothberg
Presents at CURE/Yale BioHaven
Dr. Rothberg is the founder of Ion Torrent
Systems of Guilford, CT. The company has developed a DNA sequencing system that
directly translates chemical signals into digital information on a semiconductor
chip. Ion Torrent launched the Ion Personal Genome
Machine in 2010. The Ion Personal Genome Machine (PGM™) sequencer can do a run
in about an hour, offers semiconductor scalability and is one tenth the price of
other sequencers to buy and to run, the company says.
For
the full story |
|
Connecticut
Stem Cell Research Roundup
Connecticut
– the stem cell state
The
National Institutes of Health approved four stem cell lines
developed at the UConn Stem Cell Core as eligible for use in
NIH-funded research. Separately,
Connecticut
recently announced $9.8 million in grants to support nearly two dozen stem cell research projects by scientists at the University of Connecticut and at Yale.
For the full story |
|
CURE
Member News Digest
 454
Life Sciences helps
sequence giant virus
Achillion
wins Phase 1 SBIR grant
Alexion
accelerates Japanese introduction
Amarin
ahead of schedule in triglycerides treatment trials
Applied
Spine awarded patent
Bayer
HealthCare receives orphan drug designation
BioRelix
and Dalton renew collaboration
Boehringer
Ingelheim continues worldwide growth
Bristol-Myers
Squibb authorizes stock repurchase
CMD
Bioscience awarded patent
Connecticut
Innovations gives NovaTract pre-seed support
GlaxoSmithKline
reports topline data on lupus treatment
Hartford
Hospital wins Anthem distinction
Health
Sciences International sets up as Connecticut CRO
HistoRx
gets $1.5 million from Connecticut Innovations
MiraDx
gets $1 million from Connecticut Innovations
Ipsogen
names Corinne Danan a vice president
Johnson
& Johnson SEDASYS® system wins CE Mark
MannKind
completes efficacy study re insulin product
NanoViricides
reports progress with Dengue and HIV drugs
Pfizer
and World Bank to collaborate
Vascular
Insights wins CE Mark for occlusion catheter
UConn
to renovate John Dempsey Hospital
Yale
pinpoints gene regulatory elements
For
the full story |
|
